Evidence map›Paper›PMID 31587268›Full record

Trial reportClinical and experimental immunology2020

Mucosal-associated invariant T cells and Vδ2

R F Hannaway, X Wang, M Schneider, S Slow, J Cowan, B Brockway, M R Schofield, X C Morgan, D R Murdoch, J E Ussher

Open access · bronzeAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Clinical and experimental immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Frontiers in cellular and infection microbiology · 2022
    Review
  7. Review
  8. Review
  9. Observational
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

R F HannawayDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
X WangDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
M SchneiderDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
S SlowDepartment of Pathology and Biomedical Sciences, University of Otago, Christchurch, New Zealand.
J CowanDunedin School of Medicine, University of Otago, Dunedin, New Zealand.
B BrockwayDunedin School of Medicine, University of Otago, Dunedin, New Zealand.
M R SchofieldDepartment of Mathematics and Statistics, University of Otago, Dunedin, New Zealand.
X C MorganDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
D R MurdochDepartment of Pathology and Biomedical Sciences, University of Otago, Christchurch, New Zealand.
J E UssherDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.ORCID 0000-0001-9222-7680
University of Otago · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucosal-associated invariant T (MAIT) cells and Vδ2

Indexed as

Community-Acquired InfectionsFemaleHumansMaleMiddle AgedMucosal-Associated Invariant T CellsPneumoniaReceptors, Antigen, T-Cell, gamma-deltaSputumT-LymphocytesReceptors, Antigen, T-Cell, gamma-deltacommunity-acquired pneumoniagamma delta T cellsMAIT cellsqPCRseverityVδ2+ T cells

Identifiers

PMID31587268
PMCPMC6954682
OpenAlexW2978110265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.